Changeflow GovPing Pharma & Drug Safety Patent Application: Dichrostachys glomerata Hea...
Routine Notice Added Draft

Patent Application: Dichrostachys glomerata Health Benefits

Favicon for changeflow.com ChangeBridge: Patent Apps - Therapeutics (A61P)
Published September 25th, 2024
Detected March 27th, 2026
Email

Summary

The USPTO has published a patent application (US20260083791A1) detailing methods and compositions using Dichrostachys glomerata for various health benefits, including reducing anxiety, food cravings, and stress, and improving mood and energy. The application was filed on September 25, 2024, by inventor Shil Kothari.

What changed

This document is a patent application filed with the USPTO, not a regulatory rule or guidance. It describes methods and compositions utilizing Dichrostachys glomerata for purported health and wellness benefits in mammals, such as reducing anxiety, food cravings, and stress, while improving mood, physical and mental health, energy, and happiness. The application specifies oral dosage forms like pills, capsules, liquids, lozenges, or tablets.

As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on companies. However, it indicates potential future developments in therapeutic products derived from this plant. Companies in the pharmaceutical and biotechnology sectors may wish to monitor the progress of this application and related intellectual property developments in the area of natural product-based therapeutics.

Source document (simplified)

← USPTO Patent Applications

METHODS AND COMPOSITIONS USING DICHROSTACHYS GLOMERATA TO REDUCE ANXIETY, FOOD CRAVINGS AND STRESS AND IMPROVE MOOD, PHYSICAL HEALTH, MENTAL HEALTH, ENERGY AND HAPPINESS IN A MAMMAL

Application US20260083791A1 Kind: A1 Mar 26, 2026

Inventors

Shil Kothari

Abstract

Methods and related compositions using Dichrostachys glomerata to provide a variety of health and wellness benefits in a mammal. More specifically, methods and compositions using Dichrostachys glomerata to reduce anxiety, food cravings, stress and improve mood, physical health, mental health, energy and happiness and improve other quality of life factors in one or more mammals, are provided. In one embodiment, a composition for reducing anxiety in a mammal is provided, wherein the composition comprises an effective amount of Dichrostachys glomerata fruit pods provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.

CPC Classifications

A61K 36/48 A61P 25/22

Filing Date

2024-09-25

Application No.

18896177

View original document →

Named provisions

Inventors Abstract CPC Classifications Filing Date Application No.

Classification

Agency
USPTO
Published
September 25th, 2024
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260083791A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Drug Development Therapeutic Formulations
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Public Health Healthcare

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Therapeutics (A61P) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.